Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION

Last updated on 2022-11-10 History
Report ID 174102
Drug Identification Number 02423227
Brand name AMIODARONE HYDROCHLORIDE FOR INJECTION
Common or Proper name Amiodarone Hydrochloride for Injection, USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) AMIODARONE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 3 mL vials
ATC code C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-11-09
Estimated end date 2023-01-16
Actual end date
Shortage status Actual shortage
Updated date 2022-11-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-11-10 English Compare
v2 2022-11-09 French Compare
v1 2022-11-09 English Compare

Showing 1 to 3 of 3